Company Overview

Business Description

Sector
Health Care
Industry
Health Care
Headquarters
Korea KR
Employees
86
IPO date
Nov 28, 2018

T&R Biofab Co Ltd makes 3D bioprinting systems and bioinks for research and tissue-engineering work. Its products are used to build and test living tissue structures, such as skin and other lab-made biological models, rather than to make finished consumer goods. The company mainly serves hospitals, universities, research institutes, and biotech and pharmaceutical firms that need tools for drug testing, disease research, and regenerative medicine.

It earns money by selling bioprinters, related consumables such as bioinks and printing materials, and sometimes custom development or support services tied to those systems. This means part of its business is a recurring consumables model: customers buy the equipment first and then keep purchasing materials to run experiments. That makes the company different from a standard medical device maker because it sits at the point where hardware, biology, and lab research meet.

Its role in the industry is to give researchers the tools to create more realistic tissue models without relying only on animal testing or simple cell cultures. If its systems are adopted widely, the company can become a key supplier in the early-stage workflow of tissue engineering and preclinical testing. In simple terms, it sells the machines and materials that let scientists print living tissue models in the lab.

T&R Biofab Co Ltd Investor Relations

Address
542, Industry University Convergence Center, Smart Hub, Korea Polytechnic University, 237, Sangidaehak-ro
Siheung, Gyeonggi-Do
Korea

Business Segments

Biofabrication products and services

The company develops and sells 3D bioprinting systems, bioinks, and related tissue-engineering products, and it also works on custom biofabrication projects for medical research and regenerative medicine.

Customers and revenue model

Management

Wonsoo Yun

CEO & President

Biography unavailable